Skip to content
- Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.
- Nukaya T, Sumitomo M, Sugihara E, Takeda M, Nohara S, Tanishima S, Takenaka M, Zennami K, Takahara K, Shiroki R, Saya H.
- Cancer Med. 2023 Jan 16. doi: 10.1002/cam4.5617. Epub ahead of print.
- A case report of biallelic CHEK2 heterozygous variant presenting with breast cancer.
- Soleimani T, Bourdon C, Davis J, Fortes T.
- Clin Case Rep. 2023 Jan 11 [eCollection 2023 Jan];11(1):e6820. doi: 10.1002/ccr3.6820.